<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0">
  <akn:act name="dc-code">
    <akn:meta>
      <akn:identification source="#cosilico">
        <akn:FRBRWork>
          <akn:FRBRuri value="/akn/us-dc/code/48-831.02"/>
          <akn:FRBRdate date="2025-12-31" name="retrieval"/>
          <akn:FRBRauthor href="#dc-council"/>
          <akn:FRBRcountry value="us-dc"/>
        </akn:FRBRWork>
        <akn:FRBRExpression>
          <akn:FRBRuri value="/akn/us-dc/code/48-831.02/eng@2025"/>
          <akn:FRBRdate date="2025-12-31"/>
          <akn:FRBRauthor href="#cosilico"/>
          <akn:FRBRlanguage language="en"/>
        </akn:FRBRExpression>
      </akn:identification>
    </akn:meta>
    <akn:body>
      <akn:section eId="sec_48_831_02">
        <akn:num>48-831.02</akn:num>
        <akn:heading>Definitions.</akn:heading>
<akn:subsection eId="subsec_48-831_02_1">
      <akn:num>(1)</akn:num>
      <akn:content><akn:p>“AccessRx” means the District of Columbia AccessRx program established by § 48-831.03.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_2">
      <akn:num>(2)</akn:num>
      <akn:content><akn:p>“Average wholesale price” means the wholesale price charged for a specific commodity that is assigned by the drug wholesaler and is listed in a nationally recognized drug pricing registry that is updated daily and charged to the retail pharmacy.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_3">
      <akn:num>(3)</akn:num>
      <akn:content><akn:p>“Basic component of AccessRx” includes the provision of drugs and medications for cardiac conditions and high blood pressure, diabetes, arthritis, anticoagulation, hyperlipidemia, osteoporosis, chronic obstructive pulmonary disease and asthma, incontinence, thyroid diseases, glaucoma, Parkinson’s disease, multiple sclerosis, amyotrophic lateral sclerosis, and other conditions approved by the Department. The term “basic component of AccessRx” shall also include the provision of over-the-counter medications that are prescribed by a health care provider and approved as cost-effective by the Department.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_4">
      <akn:num>(4)</akn:num>
      <akn:content><akn:p></akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_5">
      <akn:num>(5)</akn:num>
      <akn:content><akn:p>“Covered individual” means a member, participant, enrollee, contract holder, policy holder, or beneficiary of a covered entity who is provided a prescription drug benefit by the covered entity. The term “covered individual” includes a dependent or other person provided a prescription drug benefit through a policy, contract, or plan for a covered individual.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_6">
      <akn:num>(6)</akn:num>
      <akn:content><akn:p>“Department” means the Department of Health.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_7">
      <akn:num>(7)</akn:num>
      <akn:content><akn:p>“Director” means the Director of the Department of Health.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_8">
      <akn:num>(8)</akn:num>
      <akn:content><akn:p>“District” means the District of Columbia.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_9">
      <akn:num>(9)</akn:num>
      <akn:content><akn:p>“Generic drug” means a chemically equivalent copy of a brand-name drug with an expired patent.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_10">
      <akn:num>(10)</akn:num>
      <akn:content><akn:p>“Initial discounted price” for a drug means the price the Department pays D.C. Medicaid participating retail pharmacies for that drug for District of Columbia Medicaid recipients.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_11">
      <akn:num>(11)</akn:num>
      <akn:content><akn:p>“Labeler” means an entity or person that receives prescription drugs from a manufacturer or wholesaler and repackages those drugs for later retail sale and that has a labeler code from the federal Food and Drug Administration under 21 C.F.R. § 207.20.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_12">
      <akn:num>(12)</akn:num>
      <akn:content><akn:p>“Manufacturer” means a manufacturer of prescription drugs and includes a subsidiary or affiliate of a manufacturer.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_13">
      <akn:num>(13)</akn:num>
      <akn:content><akn:p>“Marketing” means advertising and promotional activities, including, but not limited to, the activities described in § 48-833.03.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_14">
      <akn:num>(14)</akn:num>
      <akn:content><akn:p>“National Drug Code registration number” means the number registered for a drug pursuant to the listing system established by the United States Food and Drug Administration under section 510 of the Federal Food, Drug, and Cosmetic Act, approved October 10, 1962 (76 Stat. 794; 21 U.S.C. § 360).</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_15">
      <akn:num>(15)</akn:num>
      <akn:content><akn:p>“Participating retail pharmacy” or “retail pharmacy” means a retail pharmacy located in the District, or another business licensed to dispense prescription drugs in the District, that participates in the program.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_16">
      <akn:num>(16)</akn:num>
      <akn:content><akn:p>“Pharmacy benefits management” means a service provided to covered entities to facilitate the provision of prescription drug benefits to covered individuals for dispensation within the District of Columbia, including negotiating pricing and other terms with drug manufacturers and retails pharmacies. “Pharmacy benefits management” may include any or all of the following:</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_17">
      <akn:num>(17)</akn:num>
      <akn:content><akn:p>“Pharmacy benefits manager” means an entity that performs pharmacy benefits management. The term “pharmacy benefits manager” includes a person or entity acting for a pharmacy benefits manager in a contractual or employment relationship in the performance of pharmacy benefits management for a covered entity.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_18">
      <akn:num>(18)</akn:num>
      <akn:content><akn:p>“Qualified resident” means a resident of the District who is eligible for the AccessRx program pursuant to this subchapter.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_19">
      <akn:num>(19)</akn:num>
      <akn:content><akn:p>“Secondary discounted price” means the initial discounted price minus any further discounts paid for out of the AccessRx Fund.</akn:p></akn:content>
    </akn:subsection><akn:subsection eId="subsec_48-831_02_20">
      <akn:num>(20)</akn:num>
      <akn:content><akn:p>“Supplemental component of AccessRx” includes all prescription drugs and medications provided under the D.C. Medicaid program excluding those provided pursuant to the basic component of AccessRx.</akn:p></akn:content>
    </akn:subsection>
      </akn:section>
    </akn:body>
  </akn:act>
</akn:akomaNtoso>
